Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 182

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2

Nagendraprabhu, Ponnuraj, Sudhandiran, Ganapasam · 2011 · Investigational New Drugs

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10637-009-9342-5

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 65

  1. Jemal A, Siegel R, Ward E (2006) Cancer statistics. CA Cancer J Clin. 56:106–130 · DOI · Paper page
  2. Su LK, Vogelstein B, Kinzler KW (1993) Association of the APC tumor suppressor protein with catenins. Science 262:1734–1737 · DOI · Paper page
  3. Ohno K, Narnshima S, Takeuchi S, Itoh K, Itoh T, Hioki K, Nomura T (2001) Effect of bacterial metabolism in the intestine on colorectal tumors induced by 1, 2- dimethylhydrazine in transgenic mice harboring human prototype C-Ha-ras genes. J Exp Clin Can Res 20:51–56
  4. Fiala E (1975) Investigations into the metabolism and mode of action of the colon carcinogen 1, 2-dimethylhydrazine. Cancer 36:2407–2412 · doi:10.1002/1097-0142(197512)36:6<2407::aid-cncr2820360620>3.0.co;2-w
  5. Umar A, Viner JL, Richmond E, Anderson WF, Hawk ET (2002) Chemoprevention of colorectal carcinogenesis. Int J Clin Oncol 7:2–26 · DOI
  6. Jedrychowski W, Maugeri U (2009) An apple a day may hold colorectal cancer at bay: recent evidence from a case-control study. Rev Environ Health 24:59–74 · DOI
  7. Ferguson LR (1994) Antimutagens as cancer chemopreventive agents in the diet. Mutat 307:395–410 · DOI · Paper page
  8. Pashkow FJ, Watumull DG, Campbell CL (2008) Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol 101:58D–68D · DOI · Paper page
  9. Miki W, Yamaguchi K, Konosu S (1982) Comparison of carotenoids in the ovaries of marine fish and shellfish. Comp Biochem Physiol B 71:7–11 · DOI
  10. Hussein G, Goto H, Oda S, Sankawa U, Matsumoto K, Watanabe H (2006) Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biol Pharm Bull 29:684–688 · DOI
  11. Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A (1995) Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxarathin. Cancer Res 55:4059–4064
  12. Kurashige M, Okimasu E, Inoue M, Utsumi K (1990) Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR 22:27–38
  13. Tang TC, Poon RT, Lau CP, Xie D, Fan ST (2005) Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol 11:1896–1902 · DOI
  14. Mazhar D, Gillmore R, Waxman J (2005) Cox and Cancer Q J M 98:711–718
  15. Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6:203–208 · DOI · Paper page
  16. Orlowski RZ, Baldwin AS Jr (2002) NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8:385–389 · DOI · Paper page
  17. Roy R, Yang J, Moses MA (2009) Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer. J Clin Oncol. In press · DOI · Paper page
  18. Curran S, Murray GI (2000) Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36:1621–1630 · DOI · Paper page
  19. Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expressionin tumor invasion. FASEB J 13:781–792 · DOI · Paper page
  20. Daniel P, Wagrowska-Danilewicz M, Danilewicz M, Stasikowska O, Malecka-Panas E (2007) Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. Int J Colorectal Dis 22:1165–1172 · DOI
  21. Zucker S, Vacirca J (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23:101–117 · DOI · Paper page
  22. Kohno M, Pouyssegur J (2006) Targeting the ERK signaling pathway in cancer therapy. Ann Med 38:200–211 · DOI · Paper page
  23. Lu R, Wang X, Chen ZF, Sun DF, Tian XQ, Fang JY (2007) Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J Biol Chem 282:12249–12259 · DOI
  24. Watson AJ (2004) Apoptosis and colorectal cancer. Gut 53:1701–1709 · DOI · Paper page
  25. Prabhu PN, Ashok kumar P, Sudhandiran G (2009) Antioxidative and antiproliferative effects of astaxanthin during the initiation stages of 1, 2-dimethyl hydrazine-induced experimental colon carcinogenesis. Fundam Clin Pharmacol 23:225–234 · DOI
  26. Ranieri G, Labriola A, Achille G, Florio G, Zito AF, Grammatica L (2002) Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int J Oncol 21:1317–1323
  27. Sriram N, Kalayarasan S, Sudhandiran G (2009) Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther 22:221–236 · DOI · Paper page
  28. Wu B, Iwakiri R, Tsunada S, Utsumi H, Kojima M, Fujise T, Ootani A, Fujimoto K (2002) iNOS enhances rat intestinal apoptosis after ischemiareperfusion. Free Radic Biol Med 33:649–658 · DOI
  29. Groot Kormelink T, Abudukelimu A, Redegeld FA (2009) Mast cells as target in cancer therapy. Curr Pharm Des 15:1868–1878 · DOI
  30. Ribatti D, Vacca A, Nico B, Crivellato E, Roncali L, Dammacco F (2001) The role of mast cells in tumour angiogenesis. Br J Haematol 115:514–521 · DOI
  31. Lee JI, Burckart GJ (1998) Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol 38:981–993 · DOI · Paper page
  32. Divya CS, Pillai MR (2006) Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. Mol Carcinog 45:320–332 · DOI · Paper page
  33. Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM (2008) Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. Int J Exp Pathol 89:466–475 · DOI
  34. Li BH, Zhao P, Liu SZ, Yu YM, Han M, Wen JK (2005) Matrix metalloproteinase-2 and tissue inhibitor of metallo-proteinase-2 in colorectal carcinoma invasion and metastasis. World J Gastroenterol 11:3046–3050 · doi:10.3748/wjg.v11.i20.3046
  35. Al-Sheneber IF, Shibata HR, Sampalis J, Jothy S (1993) Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 71:1954–1959 · doi:10.1002/1097-0142(19930315)71:6<1954::aid-cncr2820710605>3.0.co;2-#
  36. Saglam O, Garrett CR, Boulware D, Sayegh Z, Shibata D, Malafa M, Yeatman T, Cheng JQ, Sebti S, Coppola D (2007) Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia. Clin Colorectal Cancer 6:652–656 · DOI
  37. Schutte B, Nuydens R, Geerts H, Ramaekers F (1998) Annexin v binding assay as a tool to measure opoptosisin different neuronal cells. J Neurosci Meth 86:63–69 · doi:10.1016/s0165-0270(98)00147-2
  38. Thornberry N, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316 · DOI · Paper page
  39. Boussiba S (2000) Carotenogenesis in the green alga Haematococcus pluvialis: Cellular physiology and stress response. Physiol Plantarum 108:111–117 · DOI · Paper page
  40. Henmi H, Hata M, Takeuchi M (1991) Studies on the carotenoids in the muscle of salmon. Combination of astaxanthin and canthaxanthin with bovine serum-albumin and egg- albumin. Comp Biochem Physiol B 99:609–612 · DOI
  41. Tanaka T, Morishita Y, Suzui M, Kojima T, Okumura A, Mori H (1994) Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis 15:15–19 · DOI · Paper page
  42. Lee SJ, Bai SK, Lee KS, Namkoong S, Na HJ, Ha KS, Han JA, Yim SV, Chang K, Kwon YG, Lee SK, Kim YM (2003) Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IĸB kinase-dependent NF-B activation. Mol Cells 16:97–105 · DOI · Paper page
  43. Barnes PJ, Karin M (1997) Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071 · DOI · Paper page
  44. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–759 · DOI · Paper page
  45. Sen CK, Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10:709–720 · DOI · Paper page
  46. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, AsaiK KS, Kato H, Kondo M, Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785–3789
  47. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression 190 in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188 · DOI · Paper page
  48. Lin GY, Chen ZL, Lu CM, Li Y, Ping XJ, Huang R (2000) Immunohistochemical study on p53, H-rasp21, c-erbB–2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients. World J Gastroenterol 6:234–238
  49. Kelman Z (1997) PCNA: structure, functions and interactions. Oncogene 14:629–640 · DOI · Paper page
  50. Cheng HC, Chien H, Liao CH, Yang YY, Huang SY (2007) Carotenoids suppress proliferating cell nuclear antigen and cyclin D1 expression in oral carcinogenic models. J Nutr Biochem 18:667–675 · doi:10.1016/j.jnutbio.2006.10.010
  51. Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25:235–241 · DOI · Paper page
  52. Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135–142 · DOI · Paper page
  53. Henderson WR, Chi EY, Jong EC, Klebanoff SJ (1981) Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system. J Exp Med 153:520–533 · DOI
  54. Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM (2008) A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 29:880–886 · DOI
  55. Ebihara N, Takai S, Miyazaki M, Murakami A (2005) Mast cell chymase induces conjunctival epithelial cell apoptosis by a mechanism involving degradation of fibronectin. Curr Eye Res 30:429–435 · DOI
  56. Sounni NE, Noel A (2005) Membrane type-matrix metalloproteinases and tumor progression. Biochimie 87:329–342 · DOI
  57. Uria M, Stahle-Backdahl M, Seiki A, Lopez-Otin FC (1997) Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal–epithelial cell interactions. Cancer Res 57:4882–4888
  58. Dai R, Chen R, Li H (2009) Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells. Int J Oncol 34:1749–1757
  59. Price JT, Tiganis T, Agarwal A, Djakiew D, Thompson EW (1999) Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3′-kinase and phospholipase C-dependent mechanism. Cancer Res 59:5475–5478
  60. Gibson EM, Henson ES, Haney N, Villanueva J, Gibson SB (2002) Epidermal growth factor protects epithelialderived cells from tumor necrosis factor-related apoptosisinducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res 62:488–496
  61. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, Avraham S (2007) Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med 4:e186 · DOI · Paper page
  62. Wyllie AH, Kerr JF, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251–306 · DOI · Paper page
  63. Ruchko M, Gorodnya O, LeDoux SP, Alexeyev MF, Al-Mehdi AB, Gillespie MN (2005) Mitochondrial DNA damage triggers mitochondrial dysfunction and apoptosis in oxidant-challenged lung endothelial cells. Am J Physiol Lung Cell Mol Physiol 288:L530–L535 · DOI
  64. Suh Y, Afaq F, Johnson JJ, Mukhtar H (2009) A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis 30:300–307 · DOI · Paper page
  65. Lee YK, Park SY, Kim YM, Park OJ (2009) Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann N Y Acad Sci 1171:489–494 · DOI

Cited by

See all 182

Metadata

Authors
Nagendraprabhu, P., & Sudhandiran, G.
Venue
Investigational New Drugs
Published
2009-10-30
Volume
29
Issue
2
Pages
207-224
ISSN
  • 0167-6997 (ISSN-L)
  • 1573-0646
OpenAlex
W2070343356
Cited by
182
References
7
FWCI
2.77
Type
journal article
Language
en
Open access
closed
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. https://app.cochat.ai/papers/10.1007/s10637-009-9342-5
The paper
Nagendraprabhu, P., & Sudhandiran, G. (2011). Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Investigational New Drugs. https://doi.org/10.1007/s10637-009-9342-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.